CIK 0000072444 · Accelerated filer<br>Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 591212264
- Phone
- (650) 550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-04 | Lo Steven President, Chief Exec Officer | Grant or award | +151,351 | 1,841,712 | ||
| 2025-12-04 | Lo Steven President, Chief Exec Officer | Shares withheld for taxes | −54,153 | $0.37 | $20K | 1,787,559 |
| 2025-11-17 | Watson W. Mark Director | Purchase | +15,000 | $0.41 | $6K | 119,125 |
| 2025-11-17 | Watson W. Mark Director | Purchase | +5,000 | $0.41 | $2K | 124,125 |
| 2025-11-17 | HERON ELAINE J Director | Purchase | +23,217 | $0.39 | $9K | 79,783 |
| 2025-11-17 | HERON ELAINE J Director | Purchase | +16,783 | $0.41 | $7K | 96,566 |
| 2025-08-15 | Finney Kevin Director | Purchase | +50,000 | $0.35 | $18K | 154,771 |
| 2025-08-15 | Finney Kevin Director | Purchase | +50,000 | $0.37 | $19K | 204,771 |
| 2025-07-30 | Finney Kevin Director | Purchase | +25,874 | $0.38 | $10K | 104,771 |
| 2025-07-29 | Watson W. Mark Director | Purchase | +10,000 | $0.41 | $4K | 104,125 |
| 2025-07-28 | Finney Kevin Director | Purchase | +20,000 | $0.40 | $8K | 78,897 |
| 2025-07-25 | Finney Kevin Director | Purchase | +20,000 | $0.39 | $8K | 58,897 |
| 2025-07-17 | Finney Kevin Director | Purchase | +794 | $0.38 | $302 | 38,897 |
| 2025-06-13 | Finney Kevin Director | Grant or award | +6,103 | 38,103 | ||
| 2025-06-13 | Finney Kevin Director | Grant or award · Stock Option (right to buy) | +36,392 | 36,392 | ||
| 2025-06-13 | Watson W. Mark Director | Grant or award | +16,000 | 94,125 | ||
| 2025-06-13 | Watson W. Mark Director | Grant or award · Stock Option (right to buy) | +95,400 | 95,400 | ||
| 2025-06-13 | HERON ELAINE J Director | Grant or award | +16,000 | 56,566 | ||
| 2025-06-13 | HERON ELAINE J Director | Grant or award · Stock Option (right to buy) | +95,400 | 95,400 | ||
| 2025-06-13 | Wheadon David E. Director | Grant or award | +16,000 | 46,750 |
Page 3 of 10 · 198 trades